Open Nav

IGF Oncology, LLC

Find investors or development partners

  • Date:Thursday, October 18
  • Time:3:15 PM - 3:30 PM
  • Room:Elizabethan A
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:We are developing targeted cancer drugs with better efficacy and lower side effects than existing cancer drugs.
  • Company
  • Company HQ City:St. Paul
  • Company HQ Country:United States
  • Company HQ State:Minnesota                  
  • CEO/Top Company Official:Hugh McTavish, Ph.D., J.D.
  • Main Therapeutic Focus:Oncology
  • Lead Product in Development :IGF-MTX
  • Development Phase of Primary Product:Phase II
  • Size of Last Investment Round:$3.5 million
  • Total Amount Raised to Date, In All Rounds:$4 million